CRISPR Therapeutics AG (CRSP)
40.72
+0.34
(+0.83%)
USD |
NASDAQ |
Dec 20, 16:00
40.87
+0.15
(+0.37%)
Pre-Market: 20:00
CRISPR Therapeutics Market Cap: 3.476B for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals Inc | 102.31B |
| Lonza Group Ltd | 42.79B |
| AC Immune SA | 265.17M |
| Addex Therapeutics Ltd | 8.445M |
| NLS Pharmaceutics Ltd | 7.325M |
Market Cap Related Metrics
| Price to Book Value | 1.792 |
| Price | 40.72 |
| Earnings Yield | -6.88% |